Mitoxantrone treatment of secondary progressive multiple sclerosis patients with EDSS > 6.0

被引：0
|
作者：
Kallweit, U [1 ]
Rajda, E [1 ]
Poehlau, D [1 ]
机构：
[1] Kamillus Klin, Asbach, Germany
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [21] Rapid onset Mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis
    Avasarala, JR
    Cross, AH
    Clifford, DB
    Singer, BA
    Siegel, BA
    Abbey, EE
    MULTIPLE SCLEROSIS, 2003, 9 (01): : 59 - 62
  • [22] The effect of combined mitoxantrone and methylprednisolone therapy in primary and secondary progressive multiple sclerosis
    Zingler, VC
    Strupp, M
    Jahn, K
    Gross, A
    Hohlfeld, R
    Brandt, T
    NERVENARZT, 2005, 76 (06): : 740 - +
  • [23] Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosis
    Esposito, Federica
    Radaelli, Marta
    Martinelli, Vittorio
    Sormani, Maria Pia
    Boneschi, Filippo Martinelli
    Moiola, Lucia
    Rocca, Maria Assunta
    Rodegher, Mariaemma
    Comi, Giancarlo
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (12) : 1490 - 1499
  • [24] Siponimod for the treatment of secondary progressive multiple sclerosis
    Dumitrescu, Laura
    Constantinescu, Cris S.
    Tanasescu, Radu
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) : 143 - 150
  • [25] Predictive parameters of treatment success with mitoxantrone in rapidly progressive multiple sclerosis
    Spilker, C.
    Lily, O.
    Ford, H.
    Johnson, M.
    MULTIPLE SCLEROSIS, 2007, 13 : S242 - S242
  • [26] The lymphocyte subpopulation in patients with primary progressive multiple sclerosis and secondary progressive multiple sclerosis
    Belniak, Ewa
    Bojarska-Junak, Agnieszka
    Bartosik-Psujek, Halina
    Mitosek-Szewezyk, Krystyna
    Kulka, Malgorzata
    Stelmasiak, Zbigniew
    Rolinski, Jacek
    MULTIPLE SCLEROSIS, 2008, 14 : S116 - S116
  • [27] Intravenous immunoglobulin treatment for patients with primary or secondary progressive multiple sclerosis
    Pöhlau, D
    Przuntek, H
    Späth, P
    Andresen, I
    MULTIPLE SCLEROSIS, 2005, 11 : S163 - S163
  • [28] Intravenous immunoglobulin treatment for patients with primary or secondary progressive multiple sclerosis
    Pöhlau, D
    Kallweit, U
    INTRAVENOUS IMMUNOGLOBULINS IN THE THIRD MILLENNIUM, 2004, : 235 - 241
  • [29] Markers of oxidative/nitrative damage of plasma proteins correlated with EDSS and BDI scores in patients with secondary progressive multiple sclerosis
    Morel, Agnieszka
    Bijak, Michal
    Niwald, Marta
    Miller, Elzbieta
    Saluk, Joanna
    REDOX REPORT, 2017, 22 (06) : 547 - 555
  • [30] Secondary amenorrhea associated with mitoxantrone therapy in patients with multiple sclerosis
    Etemadifar, M
    Hamzehloo, A
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S226 - S226
12345